<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04471493</url>
  </required_header>
  <id_info>
    <org_study_id>ACT0116</org_study_id>
    <nct_id>NCT04471493</nct_id>
  </id_info>
  <brief_title>Pediatric and Ambulatory Research in Infectious Diseases</brief_title>
  <acronym>PARI</acronym>
  <official_title>Real Time Surveillance of Pediatric Infectious Diseases in French Ambulatory Care: PARI Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Clinique Thérapeutique Infantile du val de Marne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AFPA (Association Française de Pédiatrie Ambulatoire)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Association Clinique Thérapeutique Infantile du val de Marne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many ambulatory networks are mainly based on diagnoses made by first-line physicians not
      specifically trained to join the network. Here we aim to set up a surveillance network on
      pediatric infectious diseases with an investment in teaching with specific trainings of
      participating pediatricians, increasing in use of point of care tests, and automated data
      extraction from the computers of the pediatricians.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      107 pediatricians among the 1400 members of the French ambulatory pediatric association, AFPA
      (Association Française de Pédiatrie Ambulatoire) were involved in this survey.To belong to
      the PARI network, pediatricians have to use the same software, Axi5-Infansoft (developed by
      CompuGroup Medical, Nanterre, France) for electronic medical record of children. The
      pediatricians were trained to the use of point of care tests and to the infectious diagnoses
      (otitis, pharyngitis, varicella, bronchiolitis, influenza, pneumonia, etc..). The study
      population consisted of all children under 16 years of age from the patient population for
      which an infectious disease was diagnosed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 26, 2017</start_date>
  <completion_date type="Anticipated">March 2, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 27, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Evaluation of the number of infectious diseases</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the use of point of care tests</measure>
    <time_frame>5 years</time_frame>
    <description>Proportion of use of point of care tests and positivity rate according to the infectious diseases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the antibiotic treatments</measure>
    <time_frame>5 years</time_frame>
    <description>Proportion of each antibiotic treatments according to the infectious diseases</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400000</enrollment>
  <condition>Otitis</condition>
  <condition>Bronchiolitis</condition>
  <condition>Influenza</condition>
  <condition>Pharyngitis</condition>
  <condition>Varicella</condition>
  <condition>Pneumonia</condition>
  <condition>Gastroenteritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children under 16 years with infectious disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children under 16 years of age with at least one infectious disease among:

          -  pharyngitis

          -  otitis

          -  pneumonia

          -  influenza

          -  bronchiolitisz

          -  varicella

          -  gastroenteritis

          -  enterovirus disease

          -  bordetella pertussis disease

          -  using the same same software, Axi5-Infansoft (developed by CompuGroup Medical,
             Nanterre, France)

        Exclusion Criteria:

          -  parental refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Corinne LEVY, MD</last_name>
    <phone>0033148850404</phone>
    <email>corinne.levy@activ-france.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Béchet, MSc</last_name>
    <phone>0033148850404</phone>
    <email>stephane.bechet@activ-france.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AFPA</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne Levy, MD</last_name>
      <phone>0033148850404</phone>
      <email>corinne.levy@activ-france.fr</email>
    </contact>
    <contact_backup>
      <last_name>Stéphane Béchet, MSc</last_name>
      <phone>0033148850404</phone>
      <email>stephane.bechet@activ-france.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 8, 2020</study_first_submitted>
  <study_first_submitted_qc>July 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaccination</keyword>
  <keyword>Antibiotic treatment</keyword>
  <keyword>Point of care test</keyword>
  <keyword>automated data extraction</keyword>
  <keyword>network</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

